Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (341-350 of 768) with videos related to

Pageof 77
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
JAMA|August 5, 1992
Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980sM M Bortin, M M Horowitz, R P Gale, et al.
Blood|October 1, 1995
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host diseaseM Körbling, Y O Huh, A Durett, et al.
American Journal of Hematology|July 4, 2020
Haploidentical transplants for patients with relapse after the first allograftSamer A Srour, Piyanuch Kongtim, Gabriela Rondon, et al.
Cancer|May 13, 2006
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusionsAmar Safdar, Gilhen H Rodriguez, Benjamin Lichtiger, et al.
Oncotarget|October 3, 2015
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cellsBing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Ophthalmology|July 1, 1987
Treatment of cytomegalovirus retinopathy with ganciclovirG N Holland, Y Sidikaro, A E Kreiger, et al.
Cancer|February 4, 2023
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantationJun Zou, Piyanuch Kongtim, Betül Oran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemiaC M Seong, S Giralt, H Kantarjian, et al.
Pageof 77

Showing results (341-350 of 768) with videos related to

Sort By:
Pageof 77
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adultsJ A Englund, R E Champlin, P R Wyde, et al.
The Journal of Infectious Diseases|August 29, 2012
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionRoy F Chemaly, Harrys A Torres, Mark F Munsell, et al.
JAMA|August 5, 1992
Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980sM M Bortin, M M Horowitz, R P Gale, et al.
Blood|October 1, 1995
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host diseaseM Körbling, Y O Huh, A Durett, et al.
American Journal of Hematology|July 4, 2020
Haploidentical transplants for patients with relapse after the first allograftSamer A Srour, Piyanuch Kongtim, Gabriela Rondon, et al.
Cancer|May 13, 2006
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusionsAmar Safdar, Gilhen H Rodriguez, Benjamin Lichtiger, et al.
Oncotarget|October 3, 2015
Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cellsBing Z Carter, Po Yee Mak, Duncan H Mak, et al.
Ophthalmology|July 1, 1987
Treatment of cytomegalovirus retinopathy with ganciclovirG N Holland, Y Sidikaro, A E Kreiger, et al.
Cancer|February 4, 2023
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantationJun Zou, Piyanuch Kongtim, Betül Oran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemiaC M Seong, S Giralt, H Kantarjian, et al.
Pageof 77